People | July 16, 2022
HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
Mittal will be driving expansion of the provider network across India
Mittal will be driving expansion of the provider network across India
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)